Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-05-21 Sale |
2021-05-24 6:42 pm |
C4 Therapeutics Inc. | CCCC | Salter Malcolm Director |
755 | $37.12 | $28,026 | 15,598 (Direct) |
View |
| 2021-04-05 Sale |
2021-04-06 4:30 pm |
C4 Therapeutics Inc. | CCCC | Crystal Adam Chief Medical Officer |
15,000 | $37.77 | $566,536 | 157,292 (Direct) |
View |
| 2020-10-06 Purchase |
2020-10-06 9:30 pm |
C4 Therapeutics Inc. | CCCC | MCKEE WILLIAM Chief Financial Officer |
5,263 | $19 | $99,997 | 5,263 (Direct) |
View |
| 2020-10-06 Purchase |
2020-10-06 9:28 pm |
C4 Therapeutics Inc. | CCCC | COHEN MARC A Director 10% Owner |
5,030 | $19 | $95,570 | 2,489,455 (Indirect Direct) |
View |
| 2020-10-06 Purchase |
2020-10-06 9:26 pm |
C4 Therapeutics Inc. | CCCC | Salter Malcolm Director |
1,315 | $19 | $24,985 | 15,994 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-21 Option Award |
2021-06-21 8:22 pm |
N/A 2031-06-20 |
C4 Therapeutics Inc. | CCCC | White Lauren Chief Financial Officer |
136,000 | $0 | 136,000 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 4:16 pm |
N/A 2031-06-14 |
C4 Therapeutics Inc. | CCCC | DOWNEY BRUCE Director |
23,500 | $0 | 23,500 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 4:16 pm |
N/A 2031-06-14 |
C4 Therapeutics Inc. | CCCC | Prokupets Elena Director |
23,500 | $0 | 23,500 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 4:15 pm |
N/A 2031-06-14 |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
23,500 | $0 | 23,500 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 4:15 pm |
N/A 2031-06-14 |
C4 Therapeutics Inc. | CCCC | Salter Malcolm Director |
23,500 | $0 | 23,500 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 4:15 pm |
N/A 2031-06-14 |
C4 Therapeutics Inc. | CCCC | COHEN ALAIN J Director |
23,500 | $0 | 23,500 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 4:15 pm |
N/A 2031-06-14 |
C4 Therapeutics Inc. | CCCC | COHEN MARC A Director |
23,500 | $0 | 23,500 (Direct) |
View |
| 2021-06-14 Other |
2021-06-14 5:16 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | COHEN MARC A Director |
115,415 | $0 | 2,089,156 (Direct) |
View |
| 2021-06-14 Other |
2021-06-14 5:16 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | COHEN ALAIN J Director |
84,475 | $0 | 1,888,548 (Direct) |
View |
| 2021-04-14 Exercise |
2021-04-14 4:39 pm |
N/A 2026-07-12 |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
711 | $0 | 295,812 (Direct) |
View |
| 2021-04-14 Exercise |
2021-04-14 4:39 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
444 | $4.98 | 295,812 (Direct) |
View |
| 2021-04-13 Gift |
2021-04-14 4:39 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
2,278 | $0 | 295,812 (Direct) |
View |
| 2021-04-14 Exercise |
2021-04-14 4:39 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
267 | $2.11 | 295,812 (Direct) |
View |
| 2021-04-05 Option Award |
2021-04-06 4:31 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
233 | $37.51 | 288,159 (Direct) |
View |
| 2021-04-05 Exercise |
2021-04-06 4:30 pm |
N/A 2029-04-08 |
C4 Therapeutics Inc. | CCCC | Crystal Adam Chief Medical Officer |
15,000 | $0 | 157,292 (Direct) |
View |
| 2021-04-05 Exercise |
2021-04-06 4:30 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Crystal Adam Chief Medical Officer |
15,000 | $6.5 | 157,292 (Direct) |
View |
| 2021-04-05 Option Award |
2021-04-06 4:30 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Salter Malcolm Director |
359 | $37.51 | 16,353 (Direct) |
View |
| 2021-04-05 Option Award |
2021-04-06 4:30 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | COHEN ALAIN J Director 10% Owner |
266 | $37.51 | 4,204,023 (Direct) |
View |
| 2021-04-05 Option Award |
2021-04-06 4:30 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | COHEN MARC A Director 10% Owner |
553 | $37.51 | 4,342,751 (Direct) |
View |
| 2021-03-12 Option Award |
2021-03-16 4:17 pm |
N/A 2031-03-11 |
C4 Therapeutics Inc. | CCCC | Dubin Glenn Director |
41,200 | $0 | 41,200 (Direct) |
View |
Ownership |
2021-03-16 4:15 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Dubin Glenn Director |
0 | $0 | 790,607 (Indirect) |
View |
| 2021-02-18 Exercise |
2021-02-19 4:15 pm |
N/A 2026-07-12 |
C4 Therapeutics Inc. | CCCC | COHEN MARC A Director 10% Owner |
536 | $0 | 4,345,407 (Direct) |
View |
| 2021-02-18 Exercise |
2021-02-19 4:15 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | COHEN MARC A Director 10% Owner |
536 | $2.11 | 4,345,407 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 4:16 pm |
N/A 2031-02-10 |
C4 Therapeutics Inc. | CCCC | Wahlberg Laura Jean VP of Finance Corp Controller |
23,100 | $0 | 23,100 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 4:15 pm |
N/A 2031-02-10 |
C4 Therapeutics Inc. | CCCC | Fisher Stewart Chief Scientific Officer |
94,950 | $0 | 94,950 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 4:15 pm |
N/A 2031-02-10 |
C4 Therapeutics Inc. | CCCC | Crystal Adam Chief Medical Officer |
87,850 | $0 | 87,850 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 4:15 pm |
N/A 2031-02-10 |
C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer |
84,850 | $0 | 84,850 (Direct) |
View |
| 2020-12-11 Exercise |
2021-02-04 4:35 pm |
N/A 2026-07-12 |
C4 Therapeutics Inc. | CCCC | Fisher Stewart Chief Scientific Officer |
22,744 | $0 | 232,186 (Direct) |
View |
| 2020-12-11 Exercise |
2021-02-04 4:35 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Fisher Stewart Chief Scientific Officer |
7,114 | $2.11 | 232,186 (Direct) |
View |
| 2020-12-11 Exercise |
2021-02-04 4:35 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Fisher Stewart Chief Scientific Officer |
15,630 | $3.71 | 232,186 (Direct) |
View |
| 2021-01-22 Exercise |
2021-01-26 4:34 pm |
N/A 2026-07-12 |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
1,548 | $0 | 295,579 (Direct) |
View |
| 2021-01-22 Exercise |
2021-01-26 4:34 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
889 | $4.98 | 295,579 (Direct) |
View |
| 2021-01-22 Exercise |
2021-01-26 4:34 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
659 | $2.11 | 295,579 (Direct) |
View |
| 2020-10-06 Conversion |
2020-10-06 9:28 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | COHEN MARC A Director 10% Owner |
39,656,160 | $0 | 2,489,455 (Indirect) |
View |
| 2020-10-06 Conversion |
2020-10-06 9:27 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
1,361,937 | $0 | 97,315 (Direct) |
View |
| 2020-10-06 Conversion |
2020-10-06 9:27 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | DOWNEY BRUCE Director |
4,618,113 | $0 | 489,542 (Direct) |
View |
| 2020-10-06 Conversion |
2020-10-06 9:26 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Salter Malcolm Director |
138,488 | $0 | 15,994 (Direct) |
View |
| 2020-10-06 Conversion |
2020-10-06 9:24 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | COHEN ALAIN J Director 10% Owner |
39,656,160 | $0 | 2,484,425 (Indirect) |
View |
| 2020-10-06 Conversion |
2020-10-06 9:23 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Prokupets Elena Director |
6,711,447 | $0 | 592,873 (Indirect) |
View |
| 2020-10-01 Option Award |
2020-10-05 9:00 pm |
N/A 2030-09-30 |
C4 Therapeutics Inc. | CCCC | Salter Malcolm Director |
17,786 | $0 | 17,786 (Direct) |
View |
| 2020-10-01 Option Award |
2020-10-05 9:00 pm |
N/A 2030-09-30 |
C4 Therapeutics Inc. | CCCC | Hirsch Andrew See Remarks |
1,691,672 | $0 | 1,691,672 (Direct) |
View |
| 2020-10-01 Option Award |
2020-10-05 9:00 pm |
N/A 2030-09-30 |
C4 Therapeutics Inc. | CCCC | COHEN MARC A Director 10% Owner |
742,788 | $0 | 742,788 (Direct) |
View |
| 2020-10-01 Option Award |
2020-10-05 9:00 pm |
N/A 2030-09-30 |
C4 Therapeutics Inc. | CCCC | Prokupets Elena Director |
17,786 | $0 | 17,786 (Direct) |
View |
| 2020-10-01 Option Award |
2020-10-05 9:00 pm |
N/A 2030-09-30 |
C4 Therapeutics Inc. | CCCC | DOWNEY BRUCE Director |
17,786 | $0 | 17,786 (Direct) |
View |
| 2020-10-01 Option Award |
2020-10-05 9:00 pm |
N/A 2030-09-30 |
C4 Therapeutics Inc. | CCCC | COHEN ALAIN J Director 10% Owner |
17,786 | $0 | 17,786 (Direct) |
View |
| 2020-10-01 Option Award |
2020-10-05 9:00 pm |
N/A 2030-09-30 |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
17,786 | $0 | 17,786 (Direct) |
View |